Last quarter (Q4 2024), Citius Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Citius Pharmaceuticals's net income was $-9.42M. See Citius Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Total Revenue	$ ―	$ ―	$ ―	$ 90.00K	$ 90.00K	$ 90.00K
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ 90.00K	$ 90.00K	$ 90.00K
Operating Expense	$ 42.00M	$ 42.00M	$ 36.73M	$ 33.32M	$ 23.53M	$ 17.71M
Operating Income	$ -42.00M	$ -42.00M	$ -36.73M	$ -33.32M	$ -23.53M	$ -17.71M
Net Non Operating Interest Income Expense	$ 758.00K	$ 758.00K	$ 1.18M	$ 251.40K	$ 250.99K	$ 52.39K
Other Income Expense	$ -2.39M	$ -2.39M	$ -3.59M	$ ―	$ 1.22M	$ -110.21K
Pretax Income	$ -38.85M	$ -38.85M	$ -31.97M	$ -33.06M	$ -23.05M	$ -17.55M
Tax Provision	-	$ 576.00K	$ 576.00K	$ 576.00K	$ 1.23K	$ 741.00
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ 110.21K
Net Income Common Stockholders	$ -38.09M	$ -40.19M	$ -33.69M	$ -33.64M	$ -24.51M	$ -17.55M
Basic EPS	$ -5.97	$ -5.97	$ -5.50	$ -0.23	$ -0.23	$ -0.45
Diluted EPS	$ -5.97	$ -5.97	$ -5.50	$ -0.23	$ -0.23	$ -0.45
Basic Average Shares	$ 499.12M	$ 6.73M	$ 6.05M	$ 146.08M	$ 108.60M	$ 39.17M
Diluted Average Shares	$ 499.12M	$ 6.73M	$ 6.05M	$ 146.08M	$ ―	$ 39.17M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 42.00M	$ 42.00M	$ 36.73M	$ 33.32M	$ 23.53M	$ 17.71M
Net Income From Continuing And Discontinued Operation	$ -39.14M	$ -40.19M	$ -33.69M	$ -33.64M	$ -23.05M	$ -17.55M
Normalized Income	$ -30.15M	$ -38.46M	$ ―	$ ―	$ -18.21M	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -40.15M	$ -39.90M	$ -33.12M	$ -33.32M	$ -23.04M	$ -17.53M
EBITDA	$ -39.94M	$ -39.69M	$ -32.92M	$ -33.14M	$ -22.88M	$ -17.38M

Currency in USD

Citius Pharmaceuticals Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing